Wednesday, 7 October 2026NewsWorldBusinessTech
Latest

Lung Cancer: New Targeted Therapy Options

Italian Agency Approves Encorafenib Combination Therapy for Advanced Lung Cancer with BRAF Mutation A significant advancement in personalized cancer treatment, the Italian Medicines Agency (AIFA) has … Read more